loading page

The usefulness of OK-432 for the treatment of postoperative chylothorax in a low-birth-weight infant with trisomy 18
  • +6
  • Yoshiaki Takahashi,
  • Yoshiaki Kinoshita,
  • Takashi Kobayashi,
  • Yuhki Arai,
  • Toshiyuki Ohyama,
  • Naoki Yokota,
  • Koichi Saito,
  • Yu Sugai,
  • Shoichi Takano
Yoshiaki Takahashi
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science

Corresponding Author:[email protected]

Author Profile
Yoshiaki Kinoshita
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science
Author Profile
Takashi Kobayashi
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science
Author Profile
Yuhki Arai
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science
Author Profile
Toshiyuki Ohyama
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science
Author Profile
Naoki Yokota
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science
Author Profile
Koichi Saito
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science
Author Profile
Yu Sugai
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science
Author Profile
Shoichi Takano
Niigata University Faculty of Medicine Graduate School of Medical and Dental Science
Author Profile

Abstract

Chylothorax is a rare but life-threatening condition in neonates. We herein report the successful use of OK-432 for a low-birth-weight infant with trisomy 18 who developed refractory chylothorax after thoracic surgery. Increasing the concentration of OK-432 seems useful in cases with a lot of pleural effusion.
02 Mar 2022Submitted to Clinical Case Reports
02 Mar 2022Submission Checks Completed
02 Mar 2022Assigned to Editor
15 Mar 2022Reviewer(s) Assigned
24 Mar 2022Review(s) Completed, Editorial Evaluation Pending
18 Apr 2022Editorial Decision: Accept
May 2022Published in Clinical Case Reports volume 10 issue 5. 10.1002/ccr3.5844